These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7106169)

  • 1. Interaction of sulphinpyrazone with warfarin.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):327-31. PubMed ID: 7106169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves.
    Girolami A; Fabris F; Casonato A; Randi ML
    Clin Lab Haematol; 1982; 4(1):23-6. PubMed ID: 7067372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients].
    Nakano T; Nakamura T; Nakamura Y; Irie K; Sato K; Matsuo K; Imakyure O; Ogata K; Mishima K; Kamimura H
    Yakugaku Zasshi; 2017; 137(7):909-916. PubMed ID: 28674307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially serious interaction of warfarin with sulphinpyrazone.
    Thompson PL; Serjeant C
    Med J Aust; 1981 Jan; 1(1):41. PubMed ID: 7207296
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction.
    Birkett DJ; Miners JO; Attwood J
    Br J Clin Pharmacol; 1983 May; 15(5):567-9. PubMed ID: 6860533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Effect of Increased Free Concentrations of Warfarin Due to Protein-binding Substitution in a Combination of Tolvaptan on the PT-INR].
    Saito M; Maeda T; Ichihara T; Iwao T; Suzuki T
    Yakugaku Zasshi; 2020 Oct; 140(10):1269-1274. PubMed ID: 32684555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol.
    Staiger C; Schlicht F; Walter E; Gundert-Remy U; Hildebrandt R; de Vries J; Wang NS; Harenberg J; Weber E
    Eur J Clin Pharmacol; 1983; 25(6):797-801. PubMed ID: 6141054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin].
    Hosono T; Kondo A; Kambayashi Y; Homma M
    Yakugaku Zasshi; 2017; 137(8):999-1003. PubMed ID: 28768953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphinpyrazone metabolism during long-term therapy.
    Pedersen AK; Jakobsen P
    Br J Clin Pharmacol; 1981 Jun; 11(6):597-603. PubMed ID: 7272176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man.
    O'Reilly RA
    Circulation; 1982 Jan; 65(1):202-7. PubMed ID: 7053283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The warfarin-sulfinpyrazone interaction: stereochemical considerations.
    Toon S; Low LK; Gibaldi M; Trager WF; O'Reilly RA; Motley CH; Goulart DA
    Clin Pharmacol Ther; 1986 Jan; 39(1):15-24. PubMed ID: 3943265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphinpyrazone and warfarin: a probable drug interaction.
    Gallus A; Birkett D
    Lancet; 1980 Mar; 1(8167):535-6. PubMed ID: 6102248
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment.
    Schlicht F; Staiger C; de Vries J; Gundert-Remy U; Hildebrandt R; Harenberg J; Wang NS; Weber E
    Eur J Clin Pharmacol; 1985; 28(1):97-103. PubMed ID: 3987792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
    Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative interaction of sulfinpyrazone and phenylbutazone with racemic warfarin: alteration in vivo of free fraction of plasma warfarin.
    O'Reilly RA; Goulart DA
    J Pharmacol Exp Ther; 1981 Dec; 219(3):691-4. PubMed ID: 7299692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphinpyrazone and renal function following myocardial infarction.
    Choudhury SL; Taylor SH; Wieringa G; Swaminathan R; Morgan DB
    Eur J Clin Pharmacol; 1983; 24(6):747-50. PubMed ID: 6884411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of rifampin and warfarin.
    Self TH; Mann RB
    Chest; 1975 Apr; 67(4):490-1. PubMed ID: 1122784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
    Hata T; Kudo T; Sakai D; Takahashi H; Haraguchi N; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M; Satoh T
    Cancer Chemother Pharmacol; 2016 Aug; 78(2):389-96. PubMed ID: 27339150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal clearance of sulphinpyrazone in man.
    Lentjes EG; Russel FG; van Ginneken CA
    Eur J Clin Pharmacol; 1986; 31(4):473-8. PubMed ID: 3816927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.